Company news
Facility Monitoring Systems Ltd (FMS), part of the Trescal group, has signed a strategic UK partnership with Denmark-based UV Medico to supply and support its full range of Far-UVC (222 nm) disinfection systems.
Far-UVC is a mercury-free, chemical-free technology designed to inactivate airborne pathogens with high efficiency - up to 99.9% - including viruses such as SARS-CoV-2. Operating at a wavelength of 222 nanometres using Krypton-Chloride excimer lamps, the UV Medico platform delivers continuous, human-safe decontamination of air and surfaces in critical cleanroom and healthcare settings.
The agreement complements FMS’s existing portfolio of viable and non-viable environmental monitoring solutions, offering a combined approach to bioburden risk reduction in high-grade cleanrooms, aseptic manufacturing spaces and other regulated environments.
“Partnering with UV Medico enables us to integrate validated Far-UVC technology into contamination control strategies across life science, pharmaceutical, biotech and healthcare sectors,” said Deborah Haisman, Commercial Director at FMS. “Incorporating this with real-time monitoring will allow customers to further reduce microbial load in critical spaces, while also opening up opportunities in advanced manufacturing, semiconductor, and space assembly sectors where cleanroom compliance is essential.”
UV Medico’s UV222 devices also have wide applicability in public healthcare, food service, transport, and hygiene-sensitive environments, offering rapid, continuous disinfection even in occupied spaces.
Peter Johansen, CEO at UV Medico, added: “Combining our Far-UVC technology with FMS’s expertise and support network enables us to deliver compliant, fully integrated decontamination solutions tailored to the needs of UK customers.”
The partnership supports both companies’ commitment to delivering innovative, validated contamination control technologies to meet growing demand across critical sectors.
More information online
ILM Guide 2026/27